Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Protein-protein Interfaces02:04

Protein-protein Interfaces

14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

10.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.0K
Ligand Binding Sites02:40

Ligand Binding Sites

14.9K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
14.9K
Ligand Binding Sites02:40

Ligand Binding Sites

8.6K
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of Depression in Women With Metabolic Dysfunction-Associated Fatty Liver Disease Using Routine Blood Tests: A Five-Year Longitudinal Analysis From the UK Biobank.

Alpha psychiatry·2026
Same author

Oral microbiome modulation mitigates hyperglycemia exacerbation in gestational diabetes mellitus.

Nature communications·2026
Same author

Starmate: A Lightweight AI Assistant for Autism Caregivers Developed and Evaluated Through a User-Centered Mixed-Methods Framework.

Journal of medical systems·2026
Same author

CPT1A drives cisplatin resistance via acetylation‑dependent activation of DRP1 and mitochondrial fission in small cell lung cancer.

Cell death & disease·2026
Same author

Enhancing kinase-inhibitor activity and selectivity prediction through contrastive learning.

Nature communications·2025
Same author

Integrated Machine Learning and Structure-Based Virtual Screening Identifies Natural Product Targeting 50S Ribosome Inhibitory Activity Against <i>Cutibacterium acnes</i>.

Molecules (Basel, Switzerland)·2025

Related Experiment Video

Updated: Jan 13, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.6K

Enhancing Local Functional Structure Features to Improve Drug-Target Interaction Prediction.

Baoming Feng1, Haofan Du2, Henry H Y Tong1

  • 1Center for Artificial Intelligence Driven Drug Discovery, Faculty of Applied Sciences, Macao Polytechnic University, Macao 999708, China.

International Journal of Molecular Sciences
|October 29, 2025
PubMed
Summary

LoF-DTI enhances drug discovery by accurately predicting drug-target interactions, focusing on crucial local molecular features. This deep learning framework improves screening efficiency and identifies key binding sites for streamlined drug design.

Keywords:
attention mechanismdrug–target interactiongated cross-attentionlocal functional structuresmolecular simulationneural network

More Related Videos

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.7K

Related Experiment Videos

Last Updated: Jan 13, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

3.6K
Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.1K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.7K

Area of Science:

  • Computational chemistry
  • Bioinformatics
  • Artificial intelligence in drug discovery

Background:

  • Molecular simulation is vital for drug discovery but computationally expensive.
  • Existing deep learning models for drug-target interaction (DTI) often overlook critical local structural features.
  • Identifying these local features is key to understanding molecular recognition and improving screening.

Purpose of the Study:

  • To develop a deep learning framework, LoF-DTI, that explicitly represents and couples local functional structure features for enhanced DTI prediction.
  • To improve the efficiency and accuracy of virtual screening in drug discovery.
  • To provide interpretable insights into drug-target binding mechanisms.

Main Methods:

  • Drugs represented as molecular graphs (from SMILES) and targets as sequences.
  • Utilized a Jumping Knowledge (JK) enhanced Graph Isomorphism Network (GIN) for drug feature extraction.
  • Employed residual CNNs with N-mer statistics for target motif capture.
  • Integrated a Gated Cross-Attention (GCA) module for atom-to-residue interaction learning.

Main Results:

  • LoF-DTI achieved competitive performance across multiple DTI prediction benchmarks.
  • The framework demonstrated improved early retrieval rates crucial for virtual screening.
  • Case studies successfully identified known functional binding sites, validating the model's interpretability.

Conclusions:

  • LoF-DTI effectively prioritizes local features in both encoding and interaction for accurate DTI prediction.
  • The model offers mechanism-aware guidance, potentially streamlining the drug design pipeline.
  • LoF-DTI represents a significant advancement in leveraging deep learning for accelerated drug discovery.